Literature DB >> 3154669

Effects of calcium channel blockers on survival after myocardial infarction.

S Yusuf1, C D Furberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3154669     DOI： 10.1007/bf02209073

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  12 in total

1.  Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.

Authors:  H De Geest; H Kesteloot; J Piessens
Journal:  Acta Cardiol Suppl       Date:  1979

2.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

3.  Why do we need some large, simple randomized trials?

Authors:  S Yusuf; R Collins; R Peto
Journal:  Stat Med       Date:  1984 Oct-Dec       Impact factor: 2.373

4.  Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

Authors: 
Journal:  Eur Heart J       Date:  1984-07       Impact factor: 29.983

5.  Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).

Authors:  H N Neufeld
Journal:  Eur Heart J       Date:  1986-07       Impact factor: 29.983

6.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Authors:  R S Gibson; W E Boden; P Theroux; H D Strauss; C M Pratt; M Gheorghiade; R J Capone; M H Crawford; R C Schlant; R E Kleiger
Journal:  N Engl J Med       Date:  1986-08-14       Impact factor: 91.245

7.  Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

Authors:  J E Muller; J Morrison; P H Stone; R E Rude; B Rosner; R Roberts; D L Pearle; Z G Turi; J F Schneider; D H Serfas
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

8.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

Authors:  E Antman; J Muller; S Goldberg; R MacAlpin; M Rubenfire; B Tabatznik; C S Liang; F Heupler; S Achuff; N Reichek; E Geltman; N Z Kerin; R K Neff; E Braunwald
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

9.  Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.

Authors:  P G Hugenholtz; H R Michels; P W Serruys; R W Brower
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

10.  Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.

Authors: 
Journal:  Br Heart J       Date:  1986-11
View more
  5 in total

Review 1.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 2.  When is drug therapy warranted to prevent sudden cardiac death?

Authors:  B N Singh
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Cardiovascular therapies in the 1990s. An overview.

Authors:  R C Becker; J M Gore
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 4.  Myocardial infarction (ST-elevation).

Authors:  Abel P Wakai
Journal:  BMJ Clin Evid       Date:  2011-01-07

Review 5.  Myocardial infarction (ST-elevation).

Authors:  Abel P Wakai
Journal:  BMJ Clin Evid       Date:  2009-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.